Evaluating Extracorporeal Shockwave Therapy for Improving Upper Limb Function After Stroke in Adults Aged 25 to 65

What this Trial Is About

Stroke is a leading cause of death and long-term disability worldwide, often resulting in spasticity, which is increased muscle tightness and impaired movement. This condition affects most stroke survivors, particularly impacting the upper limb and complicating recovery of arm and hand functions needed for daily activities. Traditional treatments like oral medications and botulinum toxin injections have limitations, prompting research into new non-invasive methods such as Extracorporeal Shock Wave Therapy ESWT. The study evaluates the use of ESWT, which applies acoustic waves to spastic upper limb muscles to reduce muscle overactivity and support neuroplasticity. Participants are randomly assigned to receive either real ESWT combined with conventional physiotherapy or a sham ESWT with the same physiotherapy program. The ESWT protocol targets specific muscles with defined shock numbers, energy, and frequency, aiming to improve upper limb function in stroke survivors. Participants will be assessed at baseline, after 6 weeks of intervention, and at a 10-week follow-up. Evaluations include upper limb function tests, electrical muscle activation, and muscle force capacity. The study includes structured rehabilitation exercises such as stretching, mobility, strengthening, and functional training. These assessments and therapies help measure the impact of ESWT on muscle spasticity and arm function, with safety and long-term effects monitored throughout the study period.

Effectiveness of Extra-corporeal Shockwave Diathermy in the Management of Upper Limb Function Patients With Stroke.